Daebongls.Co.Ltd (078140) - Net Assets

Latest as of September 2025: ₩176.09 Billion KRW ≈ $119.34 Million USD

Based on the latest financial reports, Daebongls.Co.Ltd (078140) has net assets worth ₩176.09 Billion KRW (≈ $119.34 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩255.44 Billion ≈ $173.11 Million USD) and total liabilities (₩79.34 Billion ≈ $53.77 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Daebongls.Co.Ltd (078140) asset resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩176.09 Billion
% of Total Assets	68.94%
Annual Growth Rate	10.36%
5-Year Change	27.0%
10-Year Change	138.76%
Growth Volatility	10.39

Daebongls.Co.Ltd - Net Assets Trend (2011–2024)

This chart illustrates how Daebongls.Co.Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 078140 total assets for the complete picture of this company's asset base.

Annual Net Assets for Daebongls.Co.Ltd (2011–2024)

The table below shows the annual net assets of Daebongls.Co.Ltd from 2011 to 2024. For live valuation and market cap data, see 078140 market cap.

Year	Net Assets	Change
2024-12-31	₩131.77 Billion ≈ $89.30 Million	-14.01%
2023-12-31	₩153.23 Billion ≈ $103.84 Million	+30.79%
2022-12-31	₩117.16 Billion ≈ $79.40 Million	+7.09%
2021-12-31	₩109.40 Billion ≈ $74.14 Million	+5.45%
2020-12-31	₩103.75 Billion ≈ $70.31 Million	+28.39%
2019-12-31	₩80.81 Billion ≈ $54.76 Million	+8.29%
2018-12-31	₩74.62 Billion ≈ $50.57 Million	+7.79%
2017-12-31	₩69.23 Billion ≈ $46.92 Million	+10.03%
2016-12-31	₩62.92 Billion ≈ $42.64 Million	+14.02%
2015-12-31	₩55.19 Billion ≈ $37.40 Million	+11.81%
2014-12-31	₩49.36 Billion ≈ $33.45 Million	+11.55%
2013-12-31	₩44.25 Billion ≈ $29.98 Million	+11.89%
2012-12-31	₩39.54 Billion ≈ $26.80 Million	+8.17%
2011-12-31	₩36.56 Billion ≈ $24.77 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Daebongls.Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 9841565277000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	₩98.42 Billion	74.69%
Common Stock	₩5.54 Billion	4.21%
Other Components	₩27.81 Billion	21.10%
Total Equity	₩131.77 Billion	100.00%

Daebongls.Co.Ltd Competitors by Market Cap

The table below lists competitors of Daebongls.Co.Ltd ranked by their market capitalization.

Company	Market Cap
Three A Resources Bhd KLSE:0012	$81.75 Million
YHN Acquisition I Limited Unit NASDAQ:YHNAU	$81.76 Million
Grimoldi SA BA:GRIM	$81.77 Million
Railcare Group AB (publ) ST:RAIL	$81.78 Million
Industri Dan Perdagangan Bintraco Dharma Tbk PT JK:CARS	$81.74 Million
NPC Resources Bhd KLSE:5047	$81.74 Million
AB Science S.A PA:AB	$81.71 Million
Hammond Manufacturing Company Limited TO:HMM-A	$81.70 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Daebongls.Co.Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 120,726,877,310 to 131,765,092,540, a change of 11,038,215,230 (9.1%).
Net income of 7,339,459,130 contributed positively to equity growth.
Dividend payments of 926,491,080 reduced retained earnings.
Share repurchases of 2,385,676,500 reduced equity.
Other factors increased equity by 7,010,923,680.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	₩7.34 Billion	+5.57%
Dividends Paid	₩926.49 Million	-0.7%
Share Repurchases	₩2.39 Billion	-1.81%
Other Changes	₩7.01 Billion	+5.32%
Total Change	₩-	9.14%

Book Value vs Market Value Analysis

This analysis compares Daebongls.Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.90x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.92x to 0.90x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩5675.50	₩10880.00	x
2017-12-31	₩6244.51	₩10880.00	x
2018-12-31	₩6731.03	₩10880.00	x
2019-12-31	₩7288.94	₩10880.00	x
2020-12-31	₩9423.16	₩10880.00	x
2021-12-31	₩9992.64	₩10880.00	x
2022-12-31	₩10701.07	₩10880.00	x
2023-12-31	₩11027.13	₩10880.00	x
2024-12-31	₩12035.35	₩10880.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Daebongls.Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 5.57%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.81%
• Asset Turnover: 0.39x
• Equity Multiplier: 1.81x
Recent ROE (5.57%) is below the historical average (8.58%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	8.65%	8.29%	0.87x	1.20x	₩-493.19 Million
2012	8.58%	7.59%	0.95x	1.19x	₩-556.92 Million
2013	11.43%	11.41%	0.86x	1.17x	₩624.52 Million
2014	11.21%	10.44%	0.92x	1.17x	₩586.93 Million
2015	12.96%	12.19%	0.90x	1.19x	₩1.63 Billion
2016	13.33%	11.81%	0.94x	1.20x	₩2.10 Billion
2017	10.31%	10.87%	0.82x	1.16x	₩216.10 Million
2018	8.34%	8.66%	0.83x	1.16x	₩-1.24 Billion
2019	7.09%	8.24%	0.68x	1.26x	₩-2.35 Billion
2020	5.61%	7.63%	0.51x	1.44x	₩-4.55 Billion
2021	6.21%	8.18%	0.51x	1.49x	₩-4.15 Billion
2022	7.36%	9.23%	0.50x	1.59x	₩-3.09 Billion
2023	3.46%	4.77%	0.45x	1.61x	₩-7.89 Billion
2024	5.57%	7.81%	0.39x	1.81x	₩-5.84 Billion

Industry Comparison

This section compares Daebongls.Co.Ltd's net assets metrics with peer companies in the Pharmaceuticals industry.

Industry Context

Industry: Pharmaceuticals
Average net assets among peers: $76,340,880,510
Average return on equity (ROE) among peers: -0.08%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Daebongls.Co.Ltd (078140)	₩176.09 Billion	8.65%	0.45x	$81.74 Million
Sam Chun Dang Pharm. Co. Ltd (000250)	$86.63 Billion	1.55%	0.41x	$6.03 Billion
DongKoo Bio&Pharma Co. Ltd (006620)	$102.11 Billion	6.48%	0.69x	$33.52 Million
NatureCell Co.Ltd (007390)	$-16.60 Million	0.00%	0.00x	$688.81 Million
Sam-A Pharm. Co. Ltd (009300)	$79.92 Billion	4.39%	0.39x	$68.66 Million
Kyung Dong Pharmaceutical Co. Ltd (011040)	$150.62 Billion	13.47%	0.23x	$89.89 Million
WooGene B&G Co. Ltd (018620)	$22.14 Billion	0.79%	1.63x	$13.13 Million
Oscotec Inc (039200)	$94.72 Billion	-25.63%	0.40x	$990.30 Million
EstechPharma Co. Ltd (041910)	$115.63 Billion	3.31%	0.05x	$59.21 Million
Komipharm International Co. Ltd (041960)	$76.13 Billion	-8.60%	0.75x	$380.81 Million
Eagle Veterinary Technology Co.Ltd (044960)	$35.53 Billion	3.47%	0.29x	$34.35 Million

About Daebongls.Co.Ltd

KQ:078140 Korea Pharmaceuticals

Market Cap

$81.74 Million

₩120.62 Billion KRW

Market Cap Rank

#19960 Global

#1143 in Korea

Share Price

₩10880.00

Change (1 day)

-2.25%

52-Week Range

₩9560.00 - ₩14890.00

All Time High

₩23750.00